* Pharming NV, of Leiden, Holland, focused on the production of therapeutic proteins in the milk of transgenic animals, said it intends to seek a listing on the main Amsterdam Stock Exchange, under the symbol AEX, in the first quarter of 1999. The company, which listed on the pan European market, EASDAQ, in July 1998, said the second listing would give it access to the retail shareholder base in the Netherlands, establishing the company more firmly in its home market.
* Shield Diagnostics Group plc, of Dundee, Scotland has raised £2.3 million (US$3.8 million) net of expenses, through the placing of almost half a million new shares at £4.70 per share. Dealings in the new shares began on December 18. The money will fund the commercialization of the company's Afecta and homocysteine diagnostic tests, which are both indicators of cardiovascular disease.